@article{00fb2c2d0daf40d3886df78ca68de25f,
title = "Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group",
abstract = "The objective of this phase III study was to compare the efficacy of gemcitabine plus docetaxel (GD) versus docetaxel in patients with advanced breast cancer.",
keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Deoxycytidine, Female, Humans, Middle Aged, Neoplasm Metastasis, Proportional Hazards Models, Receptor, erbB-2, Taxoids",
author = "Nielsen, {Dorte Lisbet} and Bjerre, {Karsten D} and Jakobsen, {Erik H} and S{\o}ren Cold and Stenbygaard, {Lars Eric} and S{\o}rensen, {Peter G} and Claus Kamby and Susanne M{\o}ller and J{\o}rgensen, {Charlotte L T} and Michael Andersson",
year = "2011",
month = dec,
doi = "10.1200/JCO.2010.33.9507",
language = "English",
volume = "29",
pages = "4748--54",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "36",
}